A scalable, standardized platform to produce consistent, high-quality extracellular vesicles (EVs) from induced mesenchymal stem cells (MSCs) was developed recently…
AbbVie has agreed to acquire Gilgamesh Pharmaceuticals’ lead pipeline asset bretisilocin, a clinical-stage candidate designed to treat moderate-to-severe major depressive…